Target intelligence / Profile preview

Pathogens and inflammatory mediators

Molecular classification
Other
01

Overview

The term Pathogens and inflammatory mediators refers to a broad and heterogeneous category of biological entities rather than a single molecular target. Pathogens include diverse infectious agents such as bacteria, viruses, fungi, and parasites that invade a host and cause disease (StatPearls, 2023). Inflammatory mediators are endogenous signaling molecules, including cytokines (like TNF and IL-1), chemokines, and lipid mediators (like prostaglandins), that coordinate the host's immune response to injury or infection (Nature Reviews Immunology, 2020). In a clinical context, therapeutic strategies often involve either the direct eradication of pathogens using anti-infective agents or the modulation of the inflammatory response to prevent tissue damage in conditions like sepsis or rheumatoid arthritis. Because this entry encompasses thousands of distinct proteins, organisms, and chemical messengers, it is considered a functional grouping rather than a specific therapeutic target for drug discovery purposes.

Other names
Infectious agents and pro-inflammatory signaling moleculesMicrobial pathogensInflammatory cytokines and chemokines
02

Mechanism of action

Drugs targeting this category act by either directly neutralizing or inhibiting the growth of infectious pathogens (e.g., antibiotics, antivirals) or by blocking the signaling and production of host-derived inflammatory molecules (e.g., cytokine inhibitors, NSAIDs).

03

Biological functions

Immune responseInflammationPathogenesisSignal transduction
04

Disease associations

InfectionInflammationAutoimmune diseaseSepsisCancer
05

Safety considerations

ImmunosuppressionIncreased risk of opportunistic infectionsAntimicrobial resistanceCytokine release syndrome
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)ProcalcitoninInterleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)

Beyond the preview

Go deeper on Pathogens and inflammatory mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogens and inflammatory mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call